ADAM17 Rekombinanter Antikörper
ADAM17 Rekombinant Antikörper für WB, IHC, FC (Intra), Sandwich ELISA, Indirect ELISA, Sample test
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus
Anwendung
WB, IHC, FC (Intra), Sandwich ELISA, Indirect ELISA, Sample test
Konjugation
Unkonjugiert
CloneNo.
241305A2
Kat-Nr. : 84292-4-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
84292-4-PBS bindet in WB, IHC, FC (Intra), Sandwich ELISA, Indirect ELISA, Sample test ADAM17 und zeigt Reaktivität mit human, Maus
Getestete Reaktivität | human, Maus |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Rekombinant |
Typ | Antikörper |
Immunogen | ADAM17 fusion protein Ag32418 |
Vollständiger Name | ADAM metallopeptidase domain 17 |
Berechnetes Molekulargewicht | 824 aa, 93 kDa |
Beobachtetes Molekulargewicht | 100-130 kDa |
GenBank-Zugangsnummer | BC136783 |
Gene symbol | ADAM17 |
Gene ID (NCBI) | 6868 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein A purfication |
Lagerungspuffer | PBS only |
Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
The ADAMs (A Disintegrin And Metalloprotease) are multidomain transmembrane proteins. One of the first ADAMs implicated in membrane shedding is ADAM-17, which is shown to release the active form of tumor necrosis factor (TNF)-a from its precursor (PMID:18238782). ADAM17 is also named as CSVP, TACE. The full length protein has 9 glycosylation sites, a signal peptide, propeptide and 2 isoforms produced by alternative splicing.The 120-kDa form of ADAM-17 is expressed more frequently and at higher levels in primary breast carcinomas compared with normal breast tissue(PMID:17438092).